PHDA testimonials

"Both the PHDA 03 and PHDA 04 courses have made me confident working in ArcGIS, and applying principles of GIS/mapping to population health data and working on spatial analyses. In particular, what has been most helpful about these courses is applying the background theory to surveillance and research questions and walking through the analysis from start to finish, including interpretation of results."

> read full testimonial

"The GIS courses, PHDA 03 Population Health and GIS and PHDA 04 Spatial Epidemiology and Outbreak Detection provided the greatest benefits. They were excellent and introduced brand new skills for me. Prior to taking these courses I had some brief exposure to GIS within my Master’s program and through the free online PopData courses. The PHDA 03 and PHDA 04 course labs were very detailed and instructional, offering good balance between theory and practice. The courses generally had enough materials I could take away to continue working independently."

"For my current job role, PHDA 06 evaluation course reinforced work planning, stakeholder engagement planning, and reporting planning skills -- their corresponding activities are prevalent at my job."

> read full testimonial

"The GIS courses, PHDA 03 Population Health and GIS and PHDA 04 Spatial Epidemiology and Outbreak Detection provided the greatest benefits. They were excellent and introduced brand new skills for me. Prior to taking these courses I had some brief exposure to GIS within my Master’s program and through the free online PopData courses. The PHDA 03 and PHDA 04 course labs were very detailed and instructional, offering good balance between theory and practice. The courses generally had enough materials I could take away to continue working independently."

"I found PHDA 03 (Population Health and Geographic Information Systems) very interesting as it provided applicable GIS uses for health services research. I plan on increasingly incorporating GIS analyses in my health services research in order to understand another dimension of care accessibility during the end-of-life phase. "

> read full testimonial